Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Shire

Shire?uq=AFYHfsyn
1986 FOUNDED
PUBLIC STATUS
20K-25K EMPLOYEES
SHP STOCK SYMBOL
49 INVESTMENTS
$57.96 SHARE PRICE (As of Tuesday Closing)
Description

Developer and marketer of specialty medicines intended to meet needs of patient with rare diseases. The company's specialty medicines have applications in neuroscience, rare diseases, gastrointestinal, internal medicine and regenerative medicine, enabling patients with rare diseases to get affordable medicines.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
LON
Primary Office
  • Block 2 & 3 Miesian Plaza
  • 50-58 Baggot Street Lower
  • Dublin D02 Y754
  • Ireland
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Shire’s full profile, request a free trial.

Shire Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$41.78 - $60.90 $52.2B $57.10 $5.31 2.5M 915M

Shire Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 69,168,988 68,049,210 75,366,190 43,273,470
Revenue 15,527,700 15,160,600 11,396,600 6,416,700
EBITDA 5,575,300 4,726,800 2,403,600 2,060,400
Net Income 4,822,300 4,271,500 327,400 1,303,400
Total Assets 66,222,100 67,756,900 67,035,400 16,609,800
Total Debt 17,914,900 19,541,100 22,967,800 1,594,800
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Shire Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Shire‘s full profile, request access.

Request full access to PitchBook

Shire Investments & Acquisitions (49)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 06-Sep-2018 000000000000000000 Laboratory Services (Healthcare)
00000 000000000000 04-Jun-2018 00000 00000 00 000.00 Biotechnology
0000 000000000000 12-Sep-2017 00000 00000 00 0000 Drug Delivery
000000 000000 30-Jun-2017 000000000000000000 Pharmaceuticals
OncoResponse 23-Mar-2017 Early Stage VC 000.00 Biotechnology
To view this company’s complete investment and acquisition history, request access »

Shire Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 02-Jun-2016 0000 000.00 Completed
  • 7 buyers
0000000000 0000000 20-Dec-2012 00000 00000 00 0000 Completed
  • 11 buyers
DBV Technologies 05-Jan-2011 Later Stage VC 000.00 Completed
  • 8 buyers
To view this company’s complete exits history, request access »

Shire Subsidiaries (4)

Company Name Industry Location Founded
Lumena Pharmaceuticals Drug Discovery San Diego, CA 2011
00000 000000000 00 Corporate Venture Capital Wayne, PA 0000
0000000000 Laboratory Services (Healthcare) Herisau, Switzerland 0000
000 00000 00000000 Pharmaceuticals Radford, VA 0000
To view this company’s complete subsidiary history, request access »

Shire Executive Team (84)

Name Title Board
Seat
Contact
Info
William Nuerge President & Chief Executive Officer of US
Flemming Ornskov MD Chief Executive Officer & Executive Director
Thomas Dittrich Chief Financial Officer & Director
Joanne Cordeiro Chief Human Resources Officer
Karl Hick Chief Information Officer and Senior Vice President

35 Former Executives

You’re viewing 5 of 84 executives. Get the full list »

Shire Board Members (7)

Name Representing Role Since Contact
Info
000000 0.0. 000000000 Baxalta Board Member 000 0000
0000000 000000 Shire Non-Executive Director 000 0000
00000 000000 Shire Chairman 000 0000
000000 00000000 Shire Chief Financial Officer & Director 000 0000

3 Former Board Members

You’re viewing 4 of 7 board members. Get the full list »